Clarius Group LLC’s NGM Biopharmaceuticals, Inc. Common Stock NGM Stock Holding History

Clarius Group LLC’s Portfolio NGM Stock Details NGM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-26,912	Closed	-$42.8K	–	502
2024 Q1	$42.8K	Buy	26,912 +306	+1%	+$454	﹤0.01%	479
2023 Q4	$22.9K	Buy	+26,606	New	+$23.4K	﹤0.01%	476

Clarius Group LLC's NGM Position: Q2 2024 in Review

Clarius Group LLC sold out of NGM Biopharmaceuticals, Inc. Common Stock (NGM) in Q2 2024, closing a stake of 26,912 shares — an estimated $42.8K sold.

Clarius Group LLC first reported a position in NGM in Q4 2023 and held it in 2 quarters. The position peaked at $42.8K in Q1 2024. 0 funds tracked by Wall St. Rank hold NGM as of Q2 2024.

Clarius Group LLC reported no remaining NGM Biopharmaceuticals, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
Clarius Group LLC sold 26,912 NGM Biopharmaceuticals, Inc. Common Stock shares in Q2 2024, an estimated $42.8K.
Clarius Group LLC first reported a position in NGM Biopharmaceuticals, Inc. Common Stock in Q4 2023 and held it in 2 quarters.
Clarius Group LLC's NGM Biopharmaceuticals, Inc. Common Stock position peaked at $42.8K in Q1 2024.
0 funds tracked by Wall St. Rank held NGM Biopharmaceuticals, Inc. Common Stock as of Q2 2024.

Based on Clarius Group LLC's 13F filing for Q2 2024, filed 11 Jul 2024.